Xiangyu Medical Co

Xiangyu Medical Co EBIT per Share

The EBIT per Share of Xiangyu Medical Co (688626.SS) as of Nov 4, 2026 is 0.47 CNY. In the previous year, EBIT per Share was 0.70 CNY — a change of -32.03% (lower).

EBIT per Share

0.47CNY

YoY

-32.03%

Last updated:

EBIT per Share of Xiangyu Medical Co is 2025 0.47 CNY. EBIT per Share of Xiangyu Medical Co was 2024 0.70 CNY. It decreases by -32.03% lower compared to the previous year.

The Xiangyu Medical Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
1.55 CNY
Jan 1, 2022
0.88 CNY
Jan 1, 2023
1.53 CNY
Jan 1, 2024
0.70 CNY
Jan 1, 2025
0.47 CNY
Jan 1, 2026 (e)
0.69 CNY
Jan 1, 2027 (e)
0.86 CNY
Jan 1, 2028 (e)
1.06 CNY
The Xiangyu Medical Co EBIT per Share history
YEAREBIT per ShareYoY
est1.06CNY+22.97%
est0.86CNY+24.15%
est0.69CNY+45.70%
0.47CNY-32.03%
0.70CNY-54.45%
1.53CNY+75.21%
0.88CNY-43.34%
1.55CNY-16.97%
1.86CNY+54.72%
1.20CNY+107.82%
0.58CNY+21.14%
0.48CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xiangyu Medical Co Stock analysis

What does Xiangyu Medical Co do? Xiangyu Medical Co., Ltd. develops, produces, and sells rehabilitation medical equipment, focusing on intelligent rehabilitation solutions for pain, neurology, orthopedics, traditional Chinese medicine, postpartum, postoperative, and cardiopulmonary fields. The company offers three main product categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy. It primarily serves the domestic market within China, leveraging its independent research and development capabilities to address diverse rehabilitation needs across multiple medical specialties. The firm's revenue is generated through the sale of its intelligent rehabilitation equipment, with products targeting healthcare facilities, hospitals, and rehabilitation centers. These institutions purchase the equipment to support patient recovery in specialized areas such as neurology, orthopedics, and postpartum care. Xiangyu Medical's domestic market focus ensures consistent demand for its tailored rehabilitation solutions. Xiangyu Medical's business model centers on in-house research and development, enabling the creation of specialized equipment that meets the specific requirements of rehabilitation fields. By concentrating on domestic sales, the company avoids complex international distribution challenges while maintaining a strong presence in China's growing healthcare sector. The company's product portfolio aligns with the expanding demand for integrated medical care solutions within China's healthcare system. Xiangyu Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xiangyu Medical Co stock

EBIT per Share of Xiangyu Medical Co is 0.47 CNY in 2025.

EBIT per Share of Xiangyu Medical Co changed from 0.70 CNY to 0.47 CNY, representing a -32.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Xiangyu Medical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Xiangyu Medical Co

All Key Metrics — Xiangyu Medical Co